Shares of small-cap biotech company PharmAthene PIP are now trading around 27% higher at $3.07. The stock was highlighted on SeekingAlpha yesterday, and could be a beneficiary of a lawsuit that the company is engaged in with Siga Technologies SIGA.
PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
